Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Pancreatic Neoplasms 4Breast Neoplasms 3Sarcoma 2Neoplasms 2Glioblastoma 2Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Brain Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Localized Resectable Adult Primary Liver Cancer 1Jaundice 1Esophageal Neoplasms 1Duodenal Neoplasms 1Colonic Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1Childhood Brain Neoplasm 1Carcinoma, Hepatocellular 1Bites and Stings 1Biliary Tract Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Petrolatum 2Fluorouracil 2trametinib 1talimogene laherparepvec 1sargramostim 1reolysin 1pimonidazole 1pembrolizumab 1fluoromisonidazole 1dabrafenib 1Trimethoprim, Sulfamethoxazole Drug Combination 1Surgical Procedures, Operative 1Sugars 1Radiotherapy 1Radiation 1Povidone-Iodine 1Melphalan 1Granulocyte-Macrophage Colony-Stimulating Factor 1Erlotinib Hydrochloride 1Clindamycin 1Clarithromycin 1Cephalexin 1Azithromycin 1Anti-Bacterial Agents 1Amoxicillin 13-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Skin Neoplasms × Surgical Procedures, Operative × Clear all
NCT02061007 2016-05-09

Biomarker Correlates of Hypoxia in Metastatic Melanoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Withdrawn
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡